Philip Morris Supplier Sees Significant Rise in Value Rankings Despite Low Stock Price
Universal Corp's Value Ranking: Universal Corp. (UVV) has achieved a high value ranking among U.S. stocks, indicating its attractiveness to value-driven investors, with a value score of 89.96 and a growth score of 85.99.
Operational Challenges: Despite its strong value metrics, UVV faces challenges in price momentum and operational quality, with lower scores of 28.24 and 22.03, respectively, reflecting ongoing price weakness in the tobacco sector.
Strategic Supplier Role: Universal serves as a key supplier to major tobacco companies, including Philip Morris and British American Tobacco, positioning it within a significant multi-billion-dollar value chain.
Stock Performance: UVV's stock has seen a decline of 3.25% year-to-date and 4.37% over the past year, closing at $52.92, while showing slight gains in premarket trading.
Trade with 70% Backtested Accuracy
Analyst Views on BTI
About BTI
About the author

- Share Reduction Details: According to an SEC filing dated February 17, 2026, SMITH THOMAS W reduced its position in Yelp by 96,280 shares during Q4, resulting in a $4.09 million decline in value, reflecting both the sale and stock price changes, indicating a cautious outlook on Yelp's future performance.
- Remaining Stake Proportion: After the reduction, SMITH THOMAS W's remaining stake in Yelp constitutes only 0.22% of its 13F AUM, suggesting a significant loss of confidence in Yelp's investment potential, which may influence market perceptions of the company.
- Top Holdings Analysis: As of February 17, 2026, SMITH THOMAS W's top holdings include CACC valued at $42.08 million (38.9% of AUM), W at $23.81 million (22.0% of AUM), and BTI at $22.51 million (20.8% of AUM), demonstrating a diversified investment strategy and preference for other companies.
- Yelp Market Performance: As of February 17, 2026, Yelp's stock price stood at $20.68, down 45.7% over the past year, underperforming the S&P 500 by 56.53 percentage points, reflecting the challenges it faces in a competitive market environment.
- Share Reduction Details: SMITH THOMAS W sold 96,280 shares of Yelp in Q4 2026, resulting in a $4.09 million decline in position value, reflecting both stock price fluctuations and the sale itself.
- Asset Management Impact: This transaction represented a 2.75% decrease in the fund's 13F reportable assets under management (AUM), with the remaining Yelp stake now accounting for only 0.22% of AUM, thus falling outside the fund's top five holdings.
- Stock Performance Analysis: As of February 17, 2026, Yelp's stock price stood at $20.68, down 45.7% over the past year, significantly underperforming the S&P 500 by 56.53 percentage points, indicating a pessimistic market outlook on its growth potential.
- Business Model Overview: Yelp operates as a leading online platform connecting consumers with local businesses through a mix of advertising and digital solutions, with its scalable business model supported by a large user base and diverse service offerings that drive recurring revenue streams.
- Stable Cash Flows: Tobacco stocks like British American Tobacco and Philip Morris are favored during recessions due to their stable cigarette demand and strong cash flows, attracting investors seeking high dividend yields.
- Strong Growth in Smoke-Free Products: Both British American Tobacco and Philip Morris have achieved significant growth in smoke-free products, with the former known for brands like Dunhill and the latter for Marlboro, offering dividend yields of 5.62% and 3.46%, respectively, both above the S&P 500's average of 1.11%.
- Future Earnings Expectations: According to Zacks estimates, British American Tobacco's annual sales are expected to rise 7% in FY26 to $36.76 billion, while Philip Morris's sales are projected to grow 8% in FY26 to $47.14 billion, indicating strong growth potential.
- Increased Investor Confidence: Over the past 30 days, earnings per share estimates for both tobacco companies have been revised upward, earning them a Zacks Rank #2 (Buy) and being selected by experts as top stocks expected to gain over 100% in the coming year, reflecting strong market confidence in their future performance.
- Market Growth Potential: The global oral nicotine pouch market is projected to grow from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR, indicating strong consumer demand for smoke-free alternatives and driving investments and innovations from companies like Doseology.
- Product Innovation and Market Testing: Doseology's launch of Feed That Brain energy pouches in the U.S. marks its first direct-to-consumer initiative, aiming to provide sugar-free, smoke-free energy supplements, signifying the company's strategic positioning in the non-nicotine energy product sector, expected to attract health-conscious consumers.
- Strategic Leadership Change: The recent appointment of Larry Latowsky as Executive Chairman brings extensive industry experience from his tenure as President and CEO of Katz Group Canada, which is anticipated to drive sustainable growth in Doseology's oral stimulant platform and enhance market competitiveness.
- Equity Incentive Program: The company granted 140,000 restricted share units and 210,000 performance share units to a director, with the vesting schedule spread over 36 months, aimed at attracting and retaining executive talent to support the company's long-term strategic goals.
- Market Growth Potential: The global oral nicotine pouch market is projected to grow from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR, indicating strong consumer demand for smoke-free alternatives and creating market opportunities for companies like Doseology.
- Product Innovation Launch: Doseology has launched its 'Feed That Brain' energy pouches in the U.S., marking its first direct-to-consumer initiative aimed at providing sugar-free, smoke-free energy supplements that align with modern consumer preferences for health and convenience.
- Strategic Milestone: This U.S. pilot project represents a significant step for Doseology in validating oral pouch delivery as a scalable stimulant platform, with plans to evaluate consumer adoption and repeat purchase behavior, particularly targeting the demand for alternatives to traditional energy drinks.
- Leadership Change: Doseology recently appointed Larry Latowsky as Executive Chairman, whose experience from Katz Group Canada is expected to provide strategic guidance, enhance team confidence, and drive the release of long-term value.
- AST SpaceMobile Earnings Outlook: AST SpaceMobile, Inc. (NASDAQ:ASTS) is set to report its Q4 results after Monday's close, with Wall Street anticipating a loss of 16 cents per share on revenue of $41.11 million, indicating competitive pressures in the market.
- CrowdStrike Growth Target: CrowdStrike Holdings, Inc. (NASDAQ:CRWD) will release its earnings after Tuesday's close, with investors keen to see if it can achieve at least 50% year-over-year growth in net new ARR, confirming its 20% growth trajectory and justifying its premium valuation.
- Broadcom Earnings Focus: Broadcom Inc. (NASDAQ:AVGO) is expected to report its Q1 results on Wednesday afternoon, with analysts forecasting EPS of $2.02 on revenue of $19.14 billion, while investors will be watching if AI semiconductor revenue doubles to $8.2 billion.
- JD.com Earnings Preview: JD.com, Inc. (NASDAQ:JD) is expected to release its results before Thursday's open, with Wall Street predicting a loss of 3 cents per share and revenue of $50.22 billion, reflecting the challenges and opportunities in the Chinese e-commerce market.










